AAVrh.10-mediated Genetic Delivery of Bevacizumab to the Pleura to Provide Local Anti-VEGF to Suppress Growth of Metastatic Lung Tumors

Vascular endothelial growth factor (VEGF) produced by tumor cells plays a central role in stimulating angiogenesis required for tumor growth. Humanized monoclonal anti-VEGF antibody (bevacizumab, Avastin(®)), approved as a treatment for non-squamous, non-small cell lung cancer, requires administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Masaki, Boyer, Julie L., Crystal, Ronald G.
Formato: Texto
Lenguaje:English
Publicado: 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921016/
https://www.ncbi.nlm.nih.gov/pubmed/20596059
http://dx.doi.org/10.1038/gt.2010.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921016/
https://www.ncbi.nlm.nih.gov/pubmed/20596059
http://dx.doi.org/10.1038/gt.2010.87

Ejemplares similares